Browse the latest stories and reports on MSF from various media outlets.



January 12, 2013

MSF's Oliver Schulz speaks with Thomas Roberts of MSNBC about cholera and other health challenges facing Haiti three years after the earthquake.

January 07, 2013

  MSF's Ellen van der Velden explains that armed conflict is worsening a neglected humanitarian crisis in the Central African Republic.

January 04, 2013

  India's Supreme Court is expected to rule on a case with major implications for the global supply of generic medications. MSF's Leena Menghaney and Petros Isaakidis warn about the potential consequences for patients.

December 31, 2012

  The Food and Drug Administration has granted accelerated approval for bedaquiline, the first tuberculosis drug to be developed in 40 years. Bedaquiline is "a potential game changer" in treating drug-resistant tuberculosis, according to Dr. Manica Balasegaram, executive director of MSF's Access Campaign.

December 28, 2012

  Local people displaced by conflict in Central African Republic are experiencing diseases related to a lack of shelter and clean water, according to MSF's Sylvain Groulx.

December 27, 2012

Civilians are fleeing their homes in Central African Republic as rebels advance toward the capital. MSF's Sylvain Groulx reports that the conflict is exacerbating health and humanitarian conditions that were already alarming.

December 24, 2012

  A measles epidemic is endangering many children in the Democratic Republic of Congo. MSF is treating patients and administering hundreds of thousands of measles vaccinations.

December 17, 2012

MSF's Thierry Goffeau speaks about rising tensions and recruitment by armed groups in eastern Democratic Republic of Congo.

December 14, 2012

  MSF's Kate Elder explains how the for-profit model of drug and vaccine development fails to meet the needs of millions of the world's poorest and most vulnerable people. 

December 13, 2012

Experts comment on a report by MSF and the Drugs for Neglected Diseases Initiative (DNDi) which highlights the relative lack of medical research for diseases affecting millions of people in poverty.